Literature DB >> 22750866

Expression, purification, crystallization and preliminary crystallographic analysis of the phosphoglycerate kinase from Acinetobacter baumannii.

Kayla Baretta1, Craig Garen, Jiang Yin, Michael N G James.   

Abstract

Acinetobacter baumannii is a common multidrug-resistant clinical pathogen that is often found in hospitals. The A. baumannii phosphoglycerate kinase (AbPGK) is involved in the key energy-producing pathway of glycolysis and presents a potential target for antibiotic development. AbPGK has been expressed and purified; it was crystallized using lithium sulfate as the precipitant. The AbPGK crystals belonged to space group P222(1). They diffracted to a resolution of 2.5 Å using synchrotron radiation at the Canadian Light Source.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750866      PMCID: PMC3388923          DOI: 10.1107/S1744309112020222

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  9 in total

1.  Expression, purification, crystallization and preliminary X-ray diffraction studies of phosphoglycerate kinase from methicillin-resistant Staphylococcus aureus MRSA252.

Authors:  Amlan Roychowdhury; Somnath Mukherjee; Amit Kumar Das
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-25

Review 2.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

3.  Acinetobacter baumannii resistant to everything: what should we do?

Authors:  J Vila; J Pachón
Journal:  Clin Microbiol Infect       Date:  2011-07       Impact factor: 8.067

4.  Sequence, structure and activity of phosphoglycerate kinase: a possible hinge-bending enzyme.

Authors:  R D Banks; C C Blake; P R Evans; R Haser; D W Rice; G W Hardy; M Merrett; A W Phillips
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

5.  Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes.

Authors:  D M Sengstock; R Thyagarajan; J Apalara; A Mira; T Chopra; K S Kaye
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

Review 6.  Glycolysis as a target for the design of new anti-trypanosome drugs.

Authors:  C L Verlinde; V Hannaert; C Blonski; M Willson; J J Périé; L A Fothergill-Gilmore; F R Opperdoes; M H Gelb; W G Hol; P A Michels
Journal:  Drug Resist Updat       Date:  2001-02       Impact factor: 18.500

7.  Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

Authors:  Shawn R Lockhart; Murray A Abramson; Susan E Beekmann; Gale Gallagher; Stefan Riedel; Daniel J Diekema; John P Quinn; Gary V Doern
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Comparison of proteolytic susceptibility in phosphoglycerate kinases from yeast and E. coli: modulation of conformational ensembles without altering structure or stability.

Authors:  Tracy A Young; Emmanuel Skordalakes; Susan Marqusee
Journal:  J Mol Biol       Date:  2007-03-06       Impact factor: 5.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.